2.3.1.2 Indicators of Safety The safety of IVACFLU-A / H5N1 vaccine was evaluated based on the number and proportion of study subjects having adverse events (AE), which related or not related to research products according to following criteria: - Immediate reactogenicity: Number and proportion of subjects with immediate solicited local and systemic reactions which occurred within 30 minutes of each injection of research product.